taurolidine has been researched along with taurineamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillory, JK; Kirsch, LE; Sihn, YS | 1 |
| Kirsch, LE; Sihn, YS | 1 |
| Bigler, L; Fiss, I; Möhler, H; Pfirrmann, RW; Scheurer, L; Schlatterer, K; Stalder, U; Stendel, R | 1 |
3 other study(ies) available for taurolidine and taurineamide
| Article | Year |
|---|---|
Quantitation of taurolidine decomposition in polymer solutions by chromotropic acid formaldehyde assay method.
Topics: Anti-Infective Agents; Chromogenic Compounds; Drug Stability; Formaldehyde; Hydrogen-Ion Concentration; Naphthalenesulfonates; Povidone; Solutions; Spectrophotometry; Taurine; Temperature; Thiadiazines | 1997 |
The effect of polyvinylpyrrolidine on the stability of taurolidine.
Topics: Anti-Infective Agents; Drug Stability; Ions; Kinetics; Linear Models; Molecular Structure; Povidone; Taurine; Thiadiazines | 1997 |
Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
Topics: Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cyclic S-Oxides; Drug Administration Schedule; Female; Glioblastoma; Humans; Infusions, Intravenous; Male; Middle Aged; Spectrometry, Mass, Electrospray Ionization; Taurine; Thiadiazines | 2007 |